Listed company (major shareholder of other listed companies)
| Company | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|
| ASKA Pharmaceutical Holdings CO., Ltd. 4886 · FY ending Mar 2026 |
2,204,000 | 7.76% | ¥2,360 | ¥5.2B | ¥132M |
| ノイルイミューン・バイオテック株式会社 4893 · FY ending Dec 2025 |
8,119,800 | 18.75% | — | — | — |
| Chordia Therapeutics,Inc 190A · FY ending Aug 2025 |
10,760,500 | 15.59% | — | — | — |